Placeholder

C-Suite: Executive Insights

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Experts
Jed Beitler is Chairman and CEO Worldwide of Sudler & Hennessey, a global healthcare communications company. For more information, visit sudler.com.
Jay Bolling is President and CEO of Roska Healthcare Advertising, a full-service advertising agency with expertise in engaging prospects through communications that integrate data and insight-driven marketing and advertising solutions. For more information, visit roskahealthcare.com.
David de Graaf is President and CEO of ­Selventa, a personalized healthcare company that analyzes molecular patient data, accelerates the development process, and clarifies decisions on therapeutics and diagnostics for pharmaceutical and biotechnology partners. For more information, visit selventa.com.
Robert S. Epstein, M.D., is President of United BioSource Corp., a global scientific and medical affairs organization that partners with life-sciences companies to develop and commercialize their products. For more information, visit ­unitedbiosource.com.
Oliver Fetzer, Ph.D., is President and CEO of Cerulean Pharma Inc., a clinical-stage company specializing in the design and development of nanopharmaceuticals. For more information, visit ceruleanrx.com.
John Gargiulo is President and CEO of Daiichi Sankyo Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., a global pharmaceutical company, dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. For more information, visit dsi.com.
Jane Hollingsworth is CEO of NuPathe Inc., a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system. For more information, visit
nupathe.com.
RJ Lewis is President and CEO of eHealthcare Solutions, a solutions-focused advertising network specializing in the digital healthcare marketplace and providing access to the healthcare professional and consumer health audiences. For more information, visit e-healthcaresolutions.com.
Francois Nader, M.D., is President and CEO of NPS Pharmaceuticals Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders. For more information, visit npsp.com.
James T. Ogle is CEO of INC Research, a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. For more information, visit incresearch.com or follow at @inc_research.
Stuart W. Peltz, Ph.D., President and CEO of PTC Therapeutics Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes. For more information, visit ptcbio.com.
Adelene Perkins is President and CEO of Infinity Pharmaceuticals, a company dedicated to discovering, developing, and delivering to patients best-in-class medicines for difficult-to-treat diseases. For more information, visit infi.com.
Dr. Aris Persidis is President of Biovista, a privately held biotechnology company that finds novel uses for existing drugs and profiles their side effects using their mechanisms of action. For more information, visit biovista.com.
John Rodenrys is CEO of InflammaGen Therapeutics, a biotech company that has developed a new treatment, assay, and lavage to treat and diagnose multiple organ dysfunction syndrome (MODS), formally known as multi-organ failure. For more information, visit igenrx.com.
Angus Russell is CEO of Shire, a specialty biopharmaceutical company. For more information, visit shire.com.
Dr. Severin Schwan is CEO of the Roche Group, which focuses on developing medicines and diagnostics that will help patients live longer, better lives. For more information, visit roche.com.
Richard Thomas is Chief Information Officer of Quintiles, a fully integrated biopharmaceutical services company offering clinical, commercial, consulting, and capital solutions worldwide. For more information, visit quintiles.com.
Lee Valenta is President of OptumInsight Life Sciences, which specializes in technology services, information, analytics, business services, and consulting. For more information, visit optum.com.
James C. Walker is CEO and Chairman of ­Octagon Research Solutions Inc., a provider of software and services to the life-sciences industry. For more information, visit ­octagonresearch.com.

 

FEEDBACK